For the Inventor, By the Inventor

Enter assignee name

Besiktas, Turkey

Bahçesehir Üniversitesi

Calculating rank

USPTO Granted Patents = 18

EPO Patents = 6

Forward Citations = 0

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Serdar Durdagi (9 out of 9 patents)

Muge Didem Orhan (8 out of 8 patents)

Timucin Avsar (8 out of 8 patents)

4. Gurbet Cacan (5 out of 5 patents)

5. Berna Dogan (5 out of 5 patents)

6. Seyma Calis (5 out of 5 patents)

7. Mine Yurtsever (4 out of 4 patents)

8. Maide Nur Paksoy (3 out of 3 patents)

9. Gulsah Aydin (3 out of 3 patents)

10. Selcuk Ozyurt (2 out of 2 patents)

11. Bulent Aydin (2 out of 2 patents)

12. Nil Girgin (2 out of 2 patents)

13. Suleyman Semsioglu (2 out of 2 patents)

14. Sena Karali (2 out of 2 patents)

15. Kaan Alper (2 out of 2 patents)

18 patents: Sort by Forward Citations

1. 12721541 - Portable breath analysis device system and a method thereof (2026-09-01),

2. 12664425 - Method for detection of an object (2026-06-23),

3. 12661354 - DRG-MDM2-4 for use as a novel mouse double minute 2 (MDM2) inhibitor (2026-06-23),

4. 12599464 - Production of dental floss from wood fibers (2026-04-14),

5. 12595232 - DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor (2026-04-07),

6. 12528794 - MAO-B inhibitor DRG-MAOB-1 for use in treatment of neurodegenerative diseases (2026-01-20),

7. 12525393 - Production of FeNcompound as a permanent magnet (2026-01-13),

8. 12502392 - DRG-MDM2-6 for use as a novel mouse double minute 2 (MDM2) inhibitor (2025-12-23),

9. 12478613 - Selective MAO-B inhibitor DRG-MAOB-2 for use in treatment of neurodegenerative diseases (2025-11-25),

10. 12435074 - Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor (2025-10-07),

11. 12398128 - Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor (2025-08-26),

12. 12384746 - Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor (2025-08-12),

13. 12318368 - Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor (2025-06-03),

14. 12297175 - Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor (2025-05-13),

15. 12103989 - Production of polymeric material which can be cured rapidly by means of the effect of ultraviolet (UV) rays (2024-10-01),

Company Overview

Bahçesehir Üniversitesi, located in Besiktas, Turkey, is a prominent higher education institution known for its commitment to academic excellence and innovation. The university specializes in a diverse range of fields, including engineering, social sciences, health sciences, and business administration. It emphasizes research and development, fostering a collaborative environment that encourages interdisciplinary studies and partnerships with industry. The university aims to equip students with practical skills and knowledge to thrive in a globalized world.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#1 in Besiktas

#16 in Turkey

#34,263 in the World

Besiktas, Turkey

Bahçesehir Üniversitesi

Forward Citations = 0

41 inventors:

Serdar Durdagi (9 out of 9 patents)

Muge Didem Orhan (8 out of 8 patents)

Timucin Avsar (8 out of 8 patents)

4. Gurbet Cacan (5 out of 5 patents)

5. Berna Dogan (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bahçesehir Üniversitesi. Retrieved from https://idiyas.com/company/bahcesehir-universitesi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…